Distinct types of diffuse large B-cell lymphoma identified by gene expression
profiling, Nature, vol.303, issue.6769, pp.503-511, 2000. ,
DOI : 10.1038/35000501
Double-hit B-cell lymphomas, Blood, vol.117, issue.8, pp.2319-2331, 2011. ,
DOI : 10.1182/blood-2010-09-297879
Is Associated With Poor Prognosis in Patients With Diffuse Large B-Cell Lymphoma Treated in the Era of Rituximab, Journal of Clinical Oncology, vol.28, issue.20, pp.3360-3365, 2010. ,
DOI : 10.1200/JCO.2009.26.3947
Tracking CD40 signaling during germinal center development, Blood, vol.104, issue.13, pp.4088-4096, 2004. ,
DOI : 10.1182/blood-2003-12-4291
URL : http://citeseerx.ist.psu.edu/viewdoc/summary?doi=10.1.1.325.1378
Reverse engineering of regulatory networks in human B cells, Nature Genetics, vol.14, issue.4, pp.382-390, 2005. ,
DOI : 10.1101/gad.906601
The cell-cycle regulator c-Myc is essential for the formation and maintenance of germinal centers, Nature Immunology, vol.160, issue.11, pp.1092-1100, 2012. ,
DOI : 10.1016/j.immuni.2006.04.005
The IgG Fc receptor, Fcgamma RIIB, is a target for deregulation by chromosomal translocation in malignant lymphoma, Proceedings of the National Academy of Sciences, vol.97, issue.1, pp.309-314, 2000. ,
DOI : 10.1073/pnas.97.1.309
PermutMatrix: a graphical environment to arrange gene expression profiles in optimal linear order, Bioinformatics, vol.21, issue.7, pp.1280-1281, 2005. ,
DOI : 10.1093/bioinformatics/bti141
URL : https://hal.archives-ouvertes.fr/lirmm-00105307
Anti-CD47 Antibody Synergizes with Rituximab to Promote Phagocytosis and Eradicate Non-Hodgkin Lymphoma, Cell, vol.142, issue.5, pp.699-713, 2010. ,
DOI : 10.1016/j.cell.2010.07.044
Monoclonal Antibody Therapy for B-Cell Non-Hodgkin's Lymphoma, New England Journal of Medicine, vol.359, issue.6, pp.613-626, 2008. ,
DOI : 10.1056/NEJMra0708875
Statistical Validation of Peptide Identifications in Large-Scale Proteomics Using the Target-Decoy Database Search Strategy and Flexible Mixture Modeling, Journal of Proteome Research, vol.7, issue.1, pp.286-292, 2008. ,
DOI : 10.1021/pr7006818
Mutations of multiple genes cause deregulation of NF-??B in diffuse large B-cell lymphoma, Nature, vol.272, issue.7247, pp.717-721, 2009. ,
DOI : 10.1038/nature07968
MYC+ diffuse large B-cell lymphoma is not salvaged by classical R-ICE or R-DHAP followed by BEAM plus autologous stem cell transplantation, Blood, vol.119, issue.20, pp.4619-4624, 2012. ,
DOI : 10.1182/blood-2012-01-406033
URL : https://hal.archives-ouvertes.fr/inserm-00716894
BET Bromodomain Inhibition as??a Therapeutic Strategy to Target c-Myc, Cell, vol.146, issue.6, pp.904-917, 2011. ,
DOI : 10.1016/j.cell.2011.08.017
The proto-oncogene MYC is required for selection in the germinal center and cyclic reentry, Nature Immunology, vol.8, issue.11, pp.1083-1091 ,
DOI : 10.1084/jem.194.11.1625
Identification of Cellular Targets in Human Intrahepatic Cholangiocarcinoma Using Laser Microdissection and Accurate Mass and Time Tag Proteomics, Molecular & Cellular Proteomics, vol.9, issue.9, pp.1991-2004, 2010. ,
DOI : 10.1074/mcp.M110.000026
URL : https://hal.archives-ouvertes.fr/inserm-00515623
A toolbox for validation of mass spectrometry peptides identification and generation of database: IRMa, Bioinformatics, vol.25, issue.15, pp.1980-1981, 2009. ,
DOI : 10.1093/bioinformatics/btp301
Selective inhibition of BET bromodomains, Nature, vol.4, issue.7327, pp.1067-1073, 2010. ,
DOI : 10.1038/nature09504
Pathogenesis of NUT Midline Carcinoma, Annual Review of Pathology: Mechanisms of Disease, vol.7, issue.1, pp.247-265, 2012. ,
DOI : 10.1146/annurev-pathol-011811-132438
Relapsed/refractory diffuse large B-cell lymphoma. Hematol Am Soc Hematol Educ Program, pp.498-505, 2011. ,
DOI : 10.1182/asheducation-2011.1.498
Involvement of the c-jun N-terminal kinases JNK1 and JNK2 in complement-mediated cell death, Molecular Immunology, vol.47, issue.2-3, pp.310-317, 2009. ,
DOI : 10.1016/j.molimm.2009.09.016
Quantitative Proteomics Analysis of the Secretory Pathway, Cell, vol.127, issue.6, pp.1265-1281, 2006. ,
DOI : 10.1016/j.cell.2006.10.036
overexpression mimics carcinogenesis, Epigenetics, vol.4, issue.5, pp.322-329, 2009. ,
DOI : 10.4161/epi.4.5.9239
Post-meiotic Shifts in HSPA2/HSP70.2 Chaperone Activity during Mouse Spermatogenesis, Journal of Biological Chemistry, vol.281, issue.49, pp.37888-37892, 2006. ,
DOI : 10.1074/jbc.M608147200
Fas Receptor Expression in Germinal-Center B Cells Is Essential for T and B Lymphocyte Homeostasis, Immunity, vol.29, issue.4, pp.615-627, 2008. ,
DOI : 10.1016/j.immuni.2008.07.016
A Biologic Definition of Burkitt's Lymphoma from Transcriptional and Genomic Profiling, New England Journal of Medicine, vol.354, issue.23, pp.2419-2430, 2006. ,
DOI : 10.1056/NEJMoa055351
Ectopic Expression of Germline Genes Drives Malignant Brain Tumor Growth in Drosophila, Science, vol.330, issue.6012, pp.1824-1827, 2010. ,
DOI : 10.1126/science.1195481
Development of Rituximab-Resistant Lymphoma Clones with Altered Cell Signaling and Cross-Resistance to Chemotherapy, Cancer Research, vol.67, issue.3, pp.1270-1281, 2007. ,
DOI : 10.1158/0008-5472.CAN-06-2184
ZBTB2, a Novel Master Regulator of the p53 Pathway, Journal of Biological Chemistry, vol.284, issue.27, pp.17935-17946, 2009. ,
DOI : 10.1074/jbc.M809559200
Noninvasive optical imaging of ovarian metastases using Cy5- labeled RAFT-c(-RGDfK-)4, Mol Imag, vol.5, pp.188-197, 2006. ,
Lymphomas with concurrent BCL2 and MYC translocations: the critical factors associated with survival, Blood, vol.114, issue.11, pp.2273-2279, 2009. ,
DOI : 10.1182/blood-2009-03-212191
The histone variant macroH2A suppresses melanoma progression through regulation of CDK8, Nature, vol.4, issue.7327, pp.1105-1109, 2010. ,
DOI : 10.1038/nature09590
B and T cells collaborate in antiviral responses via IL-6, IL-21, and transcriptional activator and coactivator, Oct2 and OBF-1, The Journal of Experimental Medicine, vol.156, issue.11, pp.2049-2064, 2012. ,
DOI : 10.1126/science.277.5323.221
Frequent inactivation of A20 through gene mutation in B-cell lymphomas, Rinsho Ketsueki, vol.52, pp.313-319, 2009. ,
Myc suppression of Nfkb2 accelerates lymphomagenesis, BMC Cancer, vol.20, issue.14, p.348, 2010. ,
DOI : 10.1038/sj.onc.1204245
Identification, characterisation and regulation by CD40 activation of novel CD95 splice variants in CD95-apoptosis-resistant, human, B-cell non-Hodgkin's lymphoma, Experimental Cell Research, vol.315, issue.19, pp.3281-3293, 2009. ,
DOI : 10.1016/j.yexcr.2009.09.008
Novel evidence of a role for chromosome 1 pericentric heterochromatin in the pathogenesis of B-cell lymphoma and multiple myeloma, Genes, Chromosomes and Cancer, vol.111, issue.3, pp.250-264, 2001. ,
DOI : 10.1002/gcc.1189
Stromal Gene Signatures in Large-B-Cell Lymphomas, New England Journal of Medicine, vol.359, issue.22, pp.2313-2323, 2008. ,
DOI : 10.1056/NEJMoa0802885
Lentiviral vectors and transduction of human cancer B cells, Blood, vol.116, issue.3, pp.498-500, 2010. ,
DOI : 10.1182/blood-2010-03-276014
URL : https://hal.archives-ouvertes.fr/ensl-00817036
Biology of double-hit B-cell lymphomas, Current Opinion in Hematology, vol.19, issue.4, pp.299-304, 2012. ,
DOI : 10.1097/MOH.0b013e328353bbbd
Discovery and prioritization of somatic mutations in diffuse large B-cell lymphoma (DLBCL) by whole-exome sequencing, Proceedings of the National Academy of Sciences, vol.109, issue.10, pp.3879-3884, 2012. ,
DOI : 10.1073/pnas.1121343109
The genetic landscape of mutations in Burkitt lymphoma, Nature Genetics, vol.57, issue.12, pp.1321-1325, 2012. ,
DOI : 10.1126/science.1145720
Targeting MYC dependence in cancer by inhibiting BET bromodomains, Proceedings of the National Academy of Sciences, vol.108, issue.40, pp.16669-16674, 2011. ,
DOI : 10.1073/pnas.1108190108
Maintenance therapy in diffuse large B-cell lymphoma, Current Opinion in Oncology, vol.24, issue.5, pp.461-465, 2012. ,
DOI : 10.1097/CCO.0b013e3283562036
Oncogenically active MYD88 mutations in human lymphoma, Nature, vol.206, issue.7332, pp.115-119, 2011. ,
DOI : 10.1038/nature09671
BET bromodomain inhibition targets both c-Myc and IL7R in high-risk acute lymphoblastic leukemia, Blood, vol.120, issue.14, pp.2843-2852, 2012. ,
DOI : 10.1182/blood-2012-02-413021
The genetic basis of diffuse large B-cell lymphoma, Current Opinion in Hematology, vol.20, issue.4, pp.336-344, 2013. ,
DOI : 10.1097/MOH.0b013e3283623d7f
Oncogenesis by Research Article www.embomolmed.org CYCLON?induced Rituximab resistance ß 2013 The Authors, EMBO Mol Med, vol.5, pp.1180-1195, 2010. ,
New hypotheses for large-scale epigenome alterations in somatic cancer cells: a role for male germ-cell-specific regulators, Epigenomics, vol.1, issue.1, pp.153-161, 2009. ,
DOI : 10.2217/epi.09.1
Ectopic Activation of Germline and Placental Genes Identifies Aggressive Metastasis-Prone Lung Cancers, Science Translational Medicine, vol.5, issue.186, pp.186-66, 2013. ,
DOI : 10.1126/scitranslmed.3005723
URL : https://hal.archives-ouvertes.fr/hal-01261754
Regulation of Fas-mediated immune homeostasis by an activation-induced protein, Cyclon, Blood, vol.114, issue.7, pp.1355-1365, 2009. ,
DOI : 10.1182/blood-2008-11-189118
MYC gene rearrangements are associated with a poor prognosis in diffuse large B-cell lymphoma patients treated with R-CHOP chemotherapy, Blood, vol.114, issue.17, pp.3533-3537, 2009. ,
DOI : 10.1182/blood-2009-05-220095
Dissection of transcriptional programmes in response to serum and c-Myc in a human B-cell line, Oncogene, vol.24, issue.3, pp.520-524, 2005. ,
DOI : 10.1038/sj.onc.1208198
Histone macroH2A isoforms predict the risk of lung cancer recurrence, Oncogene, vol.28, issue.38, pp.3423-3428, 2009. ,
DOI : 10.1136/jcp.2005.031351
A gene atlas of the mouse and human protein-encoding transcriptomes, Proceedings of the National Academy of Sciences, vol.101, issue.16, pp.6062-6067, 2004. ,
DOI : 10.1073/pnas.0400782101
Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles, Proceedings of the National Academy of Sciences, vol.102, issue.43, pp.15545-15550, 2005. ,
DOI : 10.1073/pnas.0506580102
WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues Rituximab-mediated cell signaling and chemo/ immuno-sensitization of drug-resistant B-NHL is independent of its Fc functions, International Agency for Research, pp.6582-6594, 2008. ,
An accurate and interpretable model for siRNA efficacy prediction, BMC Bioinformatics, vol.7, issue.1, p.520, 2006. ,
DOI : 10.1186/1471-2105-7-520
URL : https://hal.archives-ouvertes.fr/hal-00433579
Patients with diffuse large B-cell lymphoma of germinal center origin with BCL2 translocations have poor outcome, irrespective of MYC status: a report from an International DLBCL rituximab-CHOP Consortium Program Study, Haematologica, vol.98, issue.2, pp.255-263, 2013. ,
DOI : 10.3324/haematol.2012.066209
Induced malignant genome reprogramming in somatic cells by testis-specific factors, Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms, vol.1809, issue.4-6, pp.221-225, 2011. ,
DOI : 10.1016/j.bbagrm.2011.04.003
Transcription factor Mef2c is required for B cell proliferation and survival after antigen receptor stimulation, Nature Immunology, vol.173, issue.6, pp.603-612, 2008. ,
DOI : 10.1038/35040593
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2518613
The molecular classification of multiple myeloma, Blood, vol.108, issue.6, pp.2020-2028, 2006. ,
DOI : 10.1182/blood-2005-11-013458
Genetic heterogeneity of diffuse large B-cell lymphoma, Proceedings of the National Academy of Sciences, vol.110, issue.4, pp.1398-1403, 2013. ,
DOI : 10.1073/pnas.1205299110
PIM1-dependent phosphorylation of histone H3 at serine 10 is required for MYC-dependent transcriptional activation and oncogenic transformation, Nature Cell Biology, vol.375, issue.8, pp.932-944, 2007. ,
DOI : 10.1038/sj.emboj.7600516
RNAi screen identifies Brd4 as a therapeutic target in acute myeloid leukaemia, Nature, vol.41, issue.7370, pp.524-528, 2011. ,
DOI : 10.1038/nature10334